Cargando…
Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential
Type 2 diabetes (T2D) is characterized by pancreatic beta-cell dysfunction, increased cell death and loss of beta-cell mass despite chronic treatment. Consequently, there has been growing interest in developing beta cell-centered therapies. Beta-cell regeneration is mediated by augmented beta-cell p...
Autores principales: | Kimani, Clare Njoki, Reuter, Helmuth, Kotzé, Sanet Henriët, Muller, Christo John Fredrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453321/ https://www.ncbi.nlm.nih.gov/pubmed/37623211 http://dx.doi.org/10.3390/cimb45080392 |
Ejemplares similares
-
Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes
por: Oh, Yoon Sin
Publicado: (2015) -
Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice
por: Mabasa, Lawrence, et al.
Publicado: (2022) -
Oxidative Stress in Pancreatic Beta Cell Regeneration
por: Wang, Jingjing, et al.
Publicado: (2017) -
Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin
por: Yin, Hao, et al.
Publicado: (2013) -
Generation of a Transgenic Zebrafish Model for Pancreatic Beta Cell Regeneration
por: Pourghadamyari, Hossein, et al.
Publicado: (2019)